Keywords: rituxan, yields, promising, results, rrms, biotechnology, major

Rituxan yields promising results in RRMS

Article | 14 May 2007

Print This

Biotechnology major Genentech and fellow USA-based Biogen Idec reported positive data from a Phase II study of Rituxan (rituximab) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in